Melinta is latest antibiotics biotech to file for bankruptcy...

US biotech Melinta Therapeutics has become the latest antibiotics specialist to file for bankruptcy, after courts said it could use its lenders’ cash to keep operating until a possible sale

Combioxin Speaking at SMi's 22nd Annual Superbugs & Superdru...

Combioxin Speaking at SMi's 22nd Annual Superbugs

UK should pay $25 million for 'Netflix' antibiotic subscript...

An expert has said the UK must pay upwards of $25 million per year to drug companies developing new antibiotics under its soon-to-be announced "Netflix" subscription model, which aims to gi

Who will pay the price for inaction on superbugs?

While the UK government has been applauded for its efforts in raising awareness about antimicrobial resistance, its efforts to convince pharma to invest in new antibiotics have so far been

As R&D shrinks, UK trials new payment scheme for antibiotics